Strategic Pharmaceutical Advisor

**Location**: Rio de Janeiro, Dakar, Nairobi, Brussels, or Kuala Lumpur
**Contract**: Permanent** -** Full time
**Starting date**:
**Deadline to apply: **
**Compensation and benefits**: MSF practice is to offer the C&B package current in the MSF entity establishing the contract.
**I. MSF INTERNATIONAL**
Médecins Sans Frontières (MSF) is an international, independent, medical humanitarian organisation that delivers emergency aid to people affected by armed conflict, epidemics, healthcare exclusion and natural disasters. MSF offers assistance to people based only on need and irrespective of race, religion, gender or political affiliation.
MSF International is the legal entity that binds MSF's 24 sections, 26 associations and 18 branch offices together. Registered in Switzerland, MSF International provides coordination, information and support to the MSF Movement, as well as implements international projects and initiatives as requested.
**II. POSITION BACKGROUND**
Access to Products for Healthcare (APH) is critical to MSF's Social Mission. It refers to the accessibility, availability, affordability, appropriateness, and quality of products for healthcare for the populations MSF assists and their communities. MSF has been engaged in a wide variety of ways to improve APH in past decades.
In 2023, the MSF International Board approved the set-up of a new organisational model for APH work in MSF. A central part of this model is the creation of an international Structure that supports the APH agenda and is overseen by an Executive Board.
MSF pharmacists working in the medical departments of MSF's operational centres, its European Supply Centres, and those who are based in regions close to MSF's medical activities, are all part of the MSF Pharmacists Network. Its objectives include assuring quality of medicines used in MSF projects, facilitating access to treatments, and providing other pharmaceutical support. The International Pharmacist Coordinator (IPC) ensures coherence and collaboration of the network; provides strategic guidance and ensures implementation of international guidelines and procedures at all levels and sections.
**III. PLACE IN THE ORGANIZATION**
The Strategic Pharmaceutical Advisor is part of the Analysis Department of the newly formed access team, reporting to the Head of Analysis. S/he works in a multidisciplinary team of the Analysis Department consisting of experts on medical, pharmaceutical, legal and policy issues related to access to health products and technologies.
The Strategic Pharmaceutical Advisor will be in close contact and collaboration with the MSF Pharmacists Network, MSF European Supply Centres, with relevant team members and other pharmacists of the APH structure, representing APH works on pharmaceutical issues in the Network.
**IV. OBJECTIVE OF THE POSITION**
- Provides advice and support on pharmaceutical related strategic development, planning, and activities of the APH structure on priority dossier and products.
- Lead the strategy and plans for the development of market landscaping analysis for the identification of barriers and potential solutions on key pharmaceutical products and technologies.
- Strategize and engage with pharmaceutical companies, product developers and key funders in relation to addressing access needs on pipelines and existing products and technologies.
- Maintains an overview of the key trends and developments related to pharmaceutical industries, pharmaceutical policies and practices at global, regional and national levels relevant to priority dossiers and products.
- Supports the development and implementation of advocacy strategies to overcome access problems of priority dossiers and products.
- Provides strategic and technical support and advice to pharmaceutical issues of other APH related projects and activities in MSF, when required.
**V. MAIN REPONSIBILITIES AND ACTIVITIES**
- ** Lead strategy for research and analysis on pharmaceutical and regulatory policies and practices and global market landscaping relevant to research and development, pricing, manufacturing sources and accessibility for priority dossiers and products/technologies**
- Support the Head of Analysis in developing the overall strategy and plan for pharmaceutical related research and analysis on agreed priority dossiers and products of the APH's Annual Plan 2025 and strategic plan .
- Leading the strategy and plans for market landscaping analysis to identify barriers and potential solutions on priority products and technologies.
- Strategizing and advising the engagement with pharmaceutical companies, product developers and key funders in relation to addressing access needs on pipelines and existing products and technologies.
- Lead monitoring, analysis and provide strategic advice on major global, regional and national trends of pharmaceutical policies and practices in relation to research and development, regulatory framework, p

---